en · de · es · fr · pt
sr9009-notes.peptides6155.com › News › Mechanism And Preclinical Findings — Evidence Review

Mechanism And Preclinical Findings — Evidence Review

By Editorial Desk · published 2026-06-23 · last reviewed 2026-07-07 · News

SR9009 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2026-07-07. Numbers and descriptions here follow the published literature rather than marketing material.

Mechanism and Preclinical Findings

SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.

Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.

Analytical Detection and Storage

Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.

Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic REV-ERB agonistSmall molecule; not a steroid or peptide.
Primary targetsNR1D1 and NR1D2Also known as REV-ERBα and REV-ERBβ.
Studied routesIntraperitoneal in rodentsOral bioavailability in humans is not established.
Human approvalNo approved therapeutic indicationNo recognized clinical use.
Key uncertaintyHuman physiological effectsPreclinical findings may not translate.

Identity, Handling, and Regulation

In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.

Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.

Related pages on this site

Background and Mechanism

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.

At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.

Notes from published material

== Climate == The climate of Stanley is classified as a subpolar oceanic climate (Köppen Cfc), bordering very closely on a polar climate (ET). Nowadays it barely avoids classification as ET because the mean temperature is greater than 10 °C (50 °F) for two months of the year. Unlike typical tundra climates, however, the winters are very mild, and vegetation grows there that normally could not in a climate this close to a polar climate. Contrast this with Churchill, Manitoba, which also has a near-tundra climate but is much more continental in nature. The Falkland Islands have displayed a warming trend in recent years; the mean daily January maximum for Mount Pleasant for the years 1999-2012 is 15.1 °C (59.2 °F) compared to Stanley's 1961-90 average of 14.1 °C (57.4 °F). Formerly, Stanley had a tundra climate (ET), due to cool summer temperatures (the mean temperature was less than 10 °C or 50 °F in the hottest month). Like the rest of the archipelago, Stanley has more or less even temperatures through the year and strong westerlies. Precipitation, averaging 544 mm (21.42 in) a year, is nonetheless relatively low, and evenly spread throughout the year. Typically, at least 1 mm (0.039 in) of rain will be recorded on 125.2 days of the year. The islands receive 36.3% of possible sunshine, or around 1500–1600 hours a year, a level similar to southern parts of England. Daytime temperatures are similar to the Northern Isles of Scotland, though nights tend to be somewhat colder, with frost occurring on more than 1 in 3 nights (128.4 nights). Snow occurs in the winter.

The Independent's Jon Sopel wrote that the most pressing issues that decided Harris's defeat were matters Biden had been perceived as a failure at by the American public; these included the fact that, as part of the global 2021–2023 inflation surge, inflation went up by 20% and real wages had not adjusted to match, and the state of the Mexico–United States border. Sopel said that by "embracing the Biden agenda, [Harris] was simply tying herself to his unpopularity". In a Time piece, Henry M. J. Tonks tied the result to the party's prioritization of professional class workers and suburbs over working class, blue-collar voters. He argued the shift away from working-class voters had been occurring since the late 1960s in response to the Vietnam War and the growth of the tech industry. Of the electoral jurisdictions that Harris won – 19 states, DC, and Nebraska's second congressional district – all except New Mexico had above-average educational attainment. CNN's Edward-Isaac Dovere felt that some of Harris' problems, such as difficulties with her staff, could have been solved, but other problems such as her ties with Biden could not. Dovere mused that had Biden stepped down earlier, the Democratic Party might have had the time to launch a proper primary campaign. He also mused that Walz was chosen because he could not "outshine" her, and that this reflected her "newfound confidence and her long-standing insecurity".

=== Protein === Additional research on sponge proteins found that of 42 sponge proteins that were analysed, all of them had homologous proteins that are found in humans. An identity score of 53% was given to the similarity among sponge and human proteins, compared to a score of 42% when the same sequence was compared to that of C. elegans.

Sources: en.wikipedia.org

Further detail

In most people, the renal threshold for glucose is about twice the normal blood glucose level. See also: Renal threshold. Kussmaul breathing The rapid, deep, and labored breathing of people who have ketoacidosis or who are in a diabetic coma. Kussmaul breathing is named for Adolph Kussmaul, the 19th century German doctor who first noted it. Also called "air hunger."

A 2005 epidemiology review concluded: "In aggregate the human epidemiological evidence is consistent with increased risk of birth defects in offspring of persons exposed to DU." Studies using cultured cells and laboratory rodents continue to suggest the possibility of leukemogenic, genetic, reproductive, and neurological effects from chronic exposure.

On 15 May 2015, the FDA issued a warning that certain SGLT2 diabetes drugs, including canagliflozin, may lead to ketoacidosis, a condition where the body produces higher levels of ketone bodies. The FDA is continuing to investigate the issue, and cautions that patients should not stop taking canagliflozin without first talking to their doctor. On 10 September 2015, the FDA issued a drug safety communication for canagliflozin to address risks for bone fracture and decreased bone density. A label warning for fractures was already included in the Adverse Reactions section; however, the FDA made the addition to the Warnings and Precautions section to reflect new information from a placebo study. They advised that health care professionals should consider fracture risk factors before prescribing canagliflozin, and patients should disclose any bone fracture risk factors to their doctors, but that patients should not stop taking the medication without first talking to their doctor. On 4 December 2015, the FDA issued another safety communication for SGLT2 inhibitors, indicating that it would require new warnings to be added to the canagliflozin label about elevated blood acid levels and urinary tract infections. In June 2016, the FDA strengthened the warning about the risk of acute kidney injury for the type 2 diabetes medicines canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR).

Sources: en.wikipedia.org

Supporting material

Two of the main functions of carbohydrates are energy storage and providing structure. The term 'sugar' typically refers to mono- and disaccharides (defined below), which fall into the former category and taste sweet. There are more carbohydrates on Earth than any other known type of biomolecule; they are used to store energy and genetic information, as well as play important roles in cell to cell interactions and communications. Carbohydrates generally have ratios of carbon:hydrogen:oxygen of 1:2:1, meaning a 1:1 ratio of carbon atoms to water (H2O), from which the term "carbohydrate" derives. The simplest type of carbohydrate is a monosaccharide, which have the chemical formula C6H12O6 but vary in their precise structures. Glucose, fructose, and galactose are hexoses, i.e. 6-carbon sugar, sharing the formula C6H12O6, but varying in precise structure. A well-known pentose, or 5-carbon sugar, is deoxyribose (C5H10O4), a component of DNA. A monosaccharide can switch between acyclic (open-chain) form and cyclic form. This occurs through reaction of one of the hydroxyl groups with the carbonyl group on the end of the linear form, bridging them with an oxygen atom and releasing a water molecule in the process. The cyclic molecule has a hemiacetal or hemiketal group, depending on whether the linear form was an aldose or a ketose, which describe the position of the carbonyl group to begin with. In these cyclic forms, the ring usually has 5 or 6 atoms.

Hand therapy is often recommended. Approximately six weeks after surgery the patient is able completely to use the hand. The average recurrence rate is 39% after a fasciectomy after a median interval of about four years.

Hydroxyzine, sold under the brand names Atarax (as hydrochloride) and Vistaril (as pamoate) among others, is an antihistamine medication. It is used in the treatment of itchiness, anxiety, insomnia, and nausea (including that due to motion sickness). It is used either by mouth or injection into a muscle. Hydroxyzine works by blocking the effects of histamine. It is a first-generation antihistamine in the piperazine family of chemicals. Common side effects include sleepiness, headache, and dry mouth. Serious side effects may include QT prolongation. It is unclear if use during pregnancy or breastfeeding is safe. It was first made by Union Chimique Belge in 1956 and was approved for sale by Pfizer in the United States later that year. In 2023, it was the 39th most commonly prescribed medication in the United States, with more than 15 million prescriptions.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.

How does SR9009 differ from typical receptor agonists?

REV-ERB receptors generally repress transcription when bound by natural heme. SR9009 is described as an agonist that enhances this repressive activity. The result is altered expression of clock and metabolic genes.

Has SR9009 been tested in humans?

Published controlled human trials are lacking. Some sources cite limited or unofficial reports, but these do not establish safety or efficacy. Claims about human performance effects remain unverified.

How is SR9009 measured?

Liquid chromatography-tandem mass spectrometry is a common approach. It can detect the parent compound and its metabolites in biological matrices.

Network